2958688

Forti G

1987

[Androgen secretion in the polycystic ovary syndrome].

2961783

Dunaif A

1988

The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome.

2961784

Waldstreicher J

1988

Hyperfunction of the hypothalamic-pituitary axis in women with polycystic ovarian disease: indirect evidence for partial gonadotroph desensitization.

2962058

Lo Dico G

1987

Central opioid activity in polycystic ovary syndrome.

2962564

el-Tabbakh GH

1987

Immunohistochemical study and quantitative estimation of beta-endorphin in polycystic ovaries.

2962909

Carlstr?m K

1987

Free testosterone and testosterone/SHBG index in hirsute women: a comparison of diagnostic accuracy.

2963503

Mahesh VB

1987

Animal models for study of polycystic ovaries and ovarian atresia.

2965034

Breckwoldt M

1988

Management of multiple conceptions after gonadotropin-releasing hormone analog/human menopausal gonadotropin/human chorionic gonadotropin therapy.

2965636

Rojanasakul A

1987

Effects of combined ethinylestradiol and desogestrel on hormone profiles and sex hormone binding globulin in women with polycystic ovarian disease.

2966223

Kubota T

1988

[Combined therapy with bromocriptine, clomiphene and gonadotropin for polycystic ovary syndrome patients failing to respond to clomiphene alone].

2966864

Jaffe R

1988

Sonographic monitoring of ovarian volume during LHRH analogue therapy in women with polycystic ovarian syndrome.

2968035

Wilson JM

1988

Conventional dose intravenous pulsatile GnRH therapy does not induce ovulation in polycystic ovarian disease.

2969192

Collins RL

1988

Beta-endorphins in ovarian follicular fluid.

2969329

Suginami H

1988

Bromocriptine treatment in anovulation with decreased ratio of follicle stimulating hormone to luteinizing hormone and with hyperandrogenism.

2969835

Shaw RW

1988

GnRH agonists-antagonists--clinical applications.

2969860

Schaison G

1987

Comparative effects of cyproterone acetate or a long-acting LHRH agonist in polycystic ovarian disease.

2970222

Wild RA

1988

The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome.

2970684

van der Weiden RM

1987

Laparoscopic ovarian electrocautery in patients with polycystic ovarian disease resistant to clomiphene citrate.

2971578

Sumioki H

1988

The effect of laparoscopic multiple punch resection of the ovary on hypothalamo-pituitary axis in polycystic ovary syndrome.

2971587

Montesanti F

1988

[Relations between polycystic ovary and idiopathic hirsutism].

2972166

Shadmi AL

1987

Abolishment of the positive feedback mechanism: a criterion for temporary medical hypophysectomy by LH-RH agonist.

2973422

Tappy L

1988

Antibodies to insulin-like growth factor I receptors in diabetes and other disorders.

2973981

Young RL

1988

Clinical manifestations of polycystic ovarian disease.

2973982

Mahajan DK

1988

Polycystic ovarian disease: animal models.

2974103

Micic D

1988

Androgen levels during sequential insulin euglycemic clamp studies in patients with polycystic ovary disease.

2975154

Eden JA

1988

Elevated free androgen index as an indicator of polycystic ovaries in oligomenorrhoea without obesity or hirsuties.

2975692

Smitz J

1988

Inhibition of gonadotropic and ovarian function by intranasal administration of D-Ser (TBU)6-EA10-LHRH in normo-ovulatory women and patients with polycystic ovary disease.

2976245

Polson DW

1988

Androstenedione concentrations following dexamethasone suppression: correlation with clomiphene responsiveness in women with polycystic ovary syndrome.

2976573

Ayalon D

1988

Induction of ovulation with D-Trp6-LHRH combined with purified FSH in patients with polycystic ovarian disease.

2976590

Eden JA

1988

Which is the best test to detect the polycystic ovary?

2977429

Negri P

1988

[Changes in plasma levels of androgens and SHBG in patients with polycystic ovary syndrome (PCOs) treated with oral contraceptives containing desogestrel].

2977519

Alieva ZA

1988

[Hormonal parameters in the polycystic ovary syndrome].

2978466

Mavroudis K

1988

Bioactive LH in women with polycystic ovaries and the effect of gonadotrophin suppression.

2982896

Pang SY

1985

Late-onset adrenal steroid 3 beta-hydroxysteroid dehydrogenase deficiency. I. A cause of hirsutism in pubertal and postpubertal women.

2985295

Ohel G

1985

Serum ACTH levels in patients with polycystic ovarian disease.

2985476

Press MF

1985

Endometrial sarcomas complicating ovarian thecoma, polycystic ovarian disease and estrogen therapy.

2987894

Schwartz FL

1985

Hirsutism. Pathophysiology, clinical evaluation, treatment.

2991021

Cobin RH

1985

Adrenocorticotropic hormone testing in idiopathic hirsutism and polycystic ovarian disease: a test of limited usefulness.

2994479

Friedman CI

1985

Serum testosterone concentrations in the evaluation of androgen-producing tumors.

2998146

Dennefors BL

1985

Ovarian steroid production in a woman with polycystic ovary syndrome associated with endometrial cancer.

3002401

Milewicz A

1985

The effect of treatment with defined spleen dialysate on plasma levels of 21-deoxycortisol and 17-hydroxyprogesterone in women with polycystic ovary disease.

3002682

McKenna TJ

1985

The adrenal cortex and virilization.

3003722

Hammond MG

1986

Hyperandrogenism. Tests that simplify evaluation.

3007079

Bhasin S

1986

Mechanisms of gonadotropin-releasing hormone agonist action in the human male.

3008481

Carmina E

1985

Late-onset 3 beta-ol-hydroxysteroid-dehydrogenase deficiency: prevalence, clinical presentation and endocrine pattern.

3009233

Schlaff WD

1986

Dynamic testing in reproductive endocrinology.

3009597

Carmina E

1986

Increased DHEAs levels in PCO syndrome: evidence for the existence of two subgroups of patients.

3010503

Ota H

1986

Enhanced ovarian gonadotropin receptors in the testosterone-induced polycystic ovary in rats.

3015693

Benjamin F

1986

Prevalence of and markers for the attenuated form of congenital adrenal hyperplasia and hyperprolactinemia masquerading as polycystic ovarian disease.

3020077

Nakamura Y

1986

Effects of luteinizing hormone and dibutyryl adenosine 3',5'-monophosphate in cultured granulosa cells from polycystic ovaries.

3020737

Ota H

1986

Ovarian membrane receptors for LH, FSH and prolactin during the menstrual cycle and in polycystic ovary syndrome.

3023147

Medina M

1986

Normal ovarian function in a mild form of late-onset 3 beta-hydroxysteroid dehydrogenase deficiency.

3030483

Iannetta O

1986

Experimental micropolycystic ovarian disease. I. Measurement of body weight, ovarian weight and histochemical activity of 17 beta-hydroxysteroid dehydrogenase.

3034691

Laatikainen T

1987

Plasma beta-endorphin, beta-lipotropin and corticotropin in polycystic ovarian disease.

3041866

Kuznetsova MN

1988

[Diagnosis and echographic control of the treatment of uterine myoma in girls and young women].

3044841

Diamond MP

1988

Alterations in carbohydrate metabolism as they apply to reproductive endocrinology.

3049852

Fujimoto S

1988

[Endocrinological environment in polycystic ovarian disease (PCOD)].

3051779

Prader A

1988

[Indications for the surgical intervention in endocrine disorders of the ovaries].

3055989

Wilson GN

1988

MCA/MR syndrome in a female infant with tetraploidy mosaicism: review of the human polyploid phenotype.

3056534

Futterweit W

1988

Ultrasonographic study of ovaries of 19 women with weight loss-related hypothalamic oligo-amenorrhea.

3058471

New MI

1988

Polycystic ovarian disease and congenital and late-onset adrenal hyperplasia.

3058472

Barbieri RL

1988

Hyperinsulinemia and ovarian hyperandrogenism. Cause and effect.

3058473

Givens JR

1988

Familial polycystic ovarian disease.

3060382

Minakami H

1988

Serum luteinizing hormone profile during the menstrual cycle in polycystic ovarian syndrome.

3062801

Bronshte?n ME

1988

[Morphofunctional characteristics of the ovaries in generalized lipodystrophy syndrome].

3063999

Bacchi Modena A

1988

[The use of pulsatile gonadotropins and gonadotropin releasing hormone analogues for ovulation induction in chronic anovulatory patients].

3067961

Futterweit W

1988

Polycystic ovarian disease: etiology, diagnosis, and treatment.

3068292

Forti G

1988

Clinical applications of GnRH analogs.

3069269

Fleming R

1988

LHRH analogues for ovulation induction, with particular reference to polycystic ovary syndrome.

3069626

Urdl W

1988

[Growth factors, carbohydrate and lipid metabolism in females with polycystic ovary syndrome].

3073113

Kubaty A

1988

[The history of Stein-Leventhal syndrome and its treatment].

3076848

Hague WM

1988

Familial polycystic ovaries: a genetic disease?

3079598

Loughlin T

1986

Adrenal abnormalities in polycystic ovary syndrome.

3079601

Gross MD

1986

Scintigraphic evidence of adrenal cortical dysfunction in the polycystic ovary syndrome.

3081105

Haxton MJ

1986

Population study of causes, treatment, and outcome of infertility.

3081669

Masaoka K

1986

[Endocrine evaluation of induction of ovulation with pulsatile and continuous administration of human menopausal gonadotropin (hMG) in anovulatory women].

3082098

Mongioi A

1986

Effect of gonadotrophin-releasing hormone analogue (GnRH-A) administration on serum gonadotrophin and steroid levels in patients with polycystic ovarian disease.

3082681

Saffan D

1986

Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders.

3085705

McLachlan RI

1986

Clinical aspects of LHRH analogues in gynaecology: a review.

3085993

Murdoch AP

1986

Studies of prolactin secretion in polycystic ovary syndrome.

3086025

Visalli N

1986

[Hypoprolactinemia in subjects with various pathologies of the reproductive system].

3086357

Dunaif A

1986

Do androgens directly regulate gonadotropin secretion in the polycystic ovary syndrome?

3086422

Paradisi R

1986

Effects of obesity on gonadotropin secretion in patients with polycystic ovarian disease.

3086957

Drapier-Faure E

1986

[A new therapeutic approach to infertility in polycystic ovaries: pure FSH].

3087090

Seifert B

1986

[Change in the diagnosis and therapy of Stein-Leventhal syndrome].

3087390

Messina M

1986

Hormonal correlations in the polycystic ovary syndrome.

3087790

Nakamura Y

1986

Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in anovulatory infertile women.

3088438

Mechanick JI

1986

The aberrant puberty hypothesis of polycystic ovarian disease: a review.

3089520

Adams J

1986

Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.

3090541

Tudose TI

1986

[Lactotropic and thyrotropic functions of the hypophysis in polycystic ovary syndrome].

3091412

Claman P

1986

Comparison of intermediate-dose purified urinary follicle-stimulating hormone with and without human chorionic gonadotropin for ovulation induction in polycystic ovarian disease.

3091442

Schwartz U

1986

[Hyperthecosis ovarii--a tumor-like change in androgenized females].

3092148

Lomeo AM

1986

[Polycystic ovaries and infertility. Incidence, characteristics, therapy and prognosis].

3093999

Tudose TI

1986

[Diagnostic value of the luliberin test with patients with polycystic ovaries].

3094734

Gordon P

1986

Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.

3095345

Givens JR

1986

Hirsutism and polycystic ovary syndrome.

3096789

Muechler EK

1986

Pregnancy induced with menotropins in a woman with polycystic ovaries, endometrial hyperplasia, and adenocarcinoma.

3096792

Burger CW

1986

Ovulation induction with pulsatile luteinizing releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: clinical results.

3097672

Givens JR

1986

Understanding the polycystic ovary syndrome.

3097673

Willemsen WN

1986

The effects of buserelin on the hormonal states in PCOD.